![Stephen D. Gillies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen D. Gillies
Chief Executive Officer at Provenance Biopharmaceuticals Corp.
Stephen D. Gillies active positions
Companies | Position | Start | End |
---|---|---|---|
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Chief Executive Officer | 31/12/2007 | - |
Founder | 31/12/2007 | - | |
President | 31/12/2007 | - | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Consultant / Advisor | - | - |
Career history of Stephen D. Gillies
Former positions of Stephen D. Gillies
Companies | Position | Start | End |
---|---|---|---|
Damon Biotech, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Abbott Biotech, Inc. | Chief Tech/Sci/R&D Officer | - | - |
APELLIS PHARMACEUTICALS, INC. | Director/Board Member | 19/07/2011 | - |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Director/Board Member | - | - |
MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Founder | - | - |
President | - | - | |
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Director/Board Member | - | - |
Training of Stephen D. Gillies
University of Massachusetts | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Statistics
International
United States | 10 |
Germany | 2 |
Hong Kong | 2 |
Operational
Director/Board Member | 3 |
Founder | 2 |
President | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MERCK KGAA | Health Technology |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 7 |
---|---|
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Health Technology |
Damon Biotech, Inc. | Health Technology |
Abbott Biotech, Inc. | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Stephen D. Gillies
- Experience